Are Medical Stocks Lagging Align Technology (ALGN) This Year?

Company Performance - Align Technology (ALGN) has outperformed the Medical sector with a year-to-date return of approximately 8.5%, while the average return for Medical companies is -1.4% [4] - The Zacks Consensus Estimate for ALGN's full-year earnings has increased by 3.7% over the past quarter, indicating stronger analyst sentiment and an improving earnings outlook [4] - Biofrontera Inc. (BFRI) has also shown strong performance, with a year-to-date return of 45.6% and a 300% increase in the consensus estimate for its current year EPS over the past three months [5] Industry Ranking - Align Technology is part of the Medical - Dental Supplies industry, which consists of 15 stocks and currently ranks 50 in the Zacks Industry Rank, with this group gaining about 1% year-to-date [6] - The Medical - Biomedical and Genetics industry, which includes Biofrontera Inc., has 444 stocks and is currently ranked 144, with a year-to-date increase of 6.4% [6] Sector Overview - The Medical sector includes 925 companies and is currently ranked 10 in the Zacks Sector Rank, which evaluates the average Zacks Rank of individual stocks within the sector [2] - The Zacks Rank system identifies stocks with characteristics likely to outperform the market in the short term, with Align Technology holding a Zacks Rank of 2 (Buy) [3]